Khavinson Bioregulators: Short Tissue-Specific Peptides Explained

Khavinson bioregulators are a group of very short peptides, usually built from two to four amino acids, that the literature describes as regulators acting within a single tissue. The name comes from Vladimir Khavinson and his team at the St. Petersburg Institute of Bioregulation and Gerontology. For a laboratory, they are a set of molecules for research models. This guide sorts out what has been studied, how the activity was interpreted, and where the available data end.

What tissue-specific short peptides are

The concept holds that a small peptide acts on cells of the tissue it was isolated from or linked to. Authors treat these molecules as local regulators rather than hormones with a broad effect. Three features come up most often:

• Low molecular weight, in the range of a few hundred daltons, for example 275.3 Da for Vilon and 418.4 Da for Pinealon.
• A short amino acid sequence, which makes synthesis and purity control straightforward.
• Activity described mainly in cell and animal models, with the focus on one target tissue.

History of the research

The work of Khavinson’s group spans several decades. The researchers started with tissue extracts and later moved to single, synthetic sequences. That shift mattered for the lab, because a short peptide of known structure can be reproduced batch after batch and results can be compared. Many publications appeared in Russian or in national journals, so much of the material is little known outside Eastern Europe.

Overview of 15 peptides by target tissue

The table below lists 15 peptides with the tissues named in this research line. It is a map of research directions, not a list of applications.

Peptide	Target tissue per literature	Structure
Epitalon	pineal gland	tetrapeptide Ala-Glu-Asp-Gly
Pinealon	nervous tissue, neurons	tripeptide Glu-Asp-Arg
Vilon	thymus and lymphoid tissue	dipeptide Lys-Glu
Thymalin	thymus	peptide complex
Cortagen	cerebral cortex	short peptide
Cardiogen	heart muscle	short peptide
Bronchogen	bronchial tissue	short peptide
Livagen	liver tissue	short peptide
Pancragen	pancreas	short peptide
Prostamax	prostate	short peptide
Cartalax	cartilage tissue	short peptide
Chonluten	mucosa of the bronchi and stomach	short peptide
Crystagen	immune system	short peptide
Vesugen	blood vessel walls	short peptide
Testagen	testicular tissue	short peptide

The most widely described peptides in the literature are those linked to the brain, the heart and the thymus. In the MOLEVIA catalogue they sit in the bioregulators category, and selected products from this group are Pinealon, Thymalin, Vilon, Cortagen and Cardiogen.

How the mechanism was described

The hypothesis cited most often is that short peptides may interact with DNA fragments or chromatin and in this way influence gene expression in cells of a given tissue. The idea is plausible, since molecules this small can enter cells more easily than large proteins. It remains a hypothesis, though. The descriptions come mainly from the authors’ own work and from in vitro models, and independent replications are limited. Stability is a separate challenge: short peptides break down quickly in biological environments, so their behaviour has been tested directly rather than assumed.

Critical assessment of the evidence

The concept has real strengths. The sequences are short, easy to synthesise and easy to check for purity, and the tissue-based model gives a clear frame for comparisons. The weaker points are these:

• Most of the data come from one research group, which makes independent assessment harder.
• Some studies describe small animal groups and abbreviated methods, so exact reproduction is difficult.
• Ageing models that appear in part of the publications do not translate directly to humans.
• In the European Union and the United States these peptides are not registered medicines, so their status is that of a research reagent.

The conclusion is simple: this is an interesting research direction that calls for your own well-designed experiments, not a ready-made answer.

Working with peptides in the laboratory

Peptides from this group are usually supplied as a lyophilisate, a dry powder. That form is more stable in storage than a solution and needs preparation according to the product sheet and your laboratory procedures before use. Each batch should have a confirmed HPLC result and molecular mass. Store reagents cold, away from light and moisture.

Where to buy research reagents at MOLEVIA

MOLEVIA sells research peptides and compounds exclusively as laboratory reagents (Research Use Only). Every item comes with purity of 99% or higher (HPLC) and mass confirmed by MS. Orders placed by 2:00 PM on business days ship the same day. Poland’s InPost parcel lockers receive the parcel on the next business day, and DPD deliveries across Europe arrive in 2-4 business days. Pay online by card, Apple Pay, Google Pay or BLIK (PLN only). Free delivery from 75 EUR, 65 GBP, 80 USD. Orders from 50 EUR (40 GBP, 55 USD) with a peptide in a vial also include 10 ml of bacteriostatic water free of charge.

Key takeaways

• Khavinson bioregulators are short peptides described as regulators of specific tissues.
• The table covers 15 molecules with their target tissues according to the literature.
• The mechanisms remain hypotheses, and most data come from in vitro and animal models.
• Broad, independent replications are lacking, so treat the results as a starting point for your own research.
• MOLEVIA reagents come with purity of 99% or higher (HPLC) and confirmed mass (MS).
• For research in this group we recommend Pinealon, Thymalin, Vilon, Cortagen and Cardiogen.